Observational Study, for Quality Assessment, of Sarcoma in European and Latin American Multidisciplinary NETWORK
Observational Study, for Quality Assessment, of Sarcoma As a Model to Improve Diagnosis and Clinical Care of Rare Tumors Through a European and Latin American Multidisciplinary NETWORK
Grupo Espanol de Investigacion en Sarcomas
5,000 participants
Jun 30, 2019
OBSERVATIONAL
Conditions
Summary
Post-authorisation, multicentric, observational, retrospective and prospective study to assess quality of care of sarcoma patients in expert and non-expert centers by analysing correlation of quality items and outcomes such as relapse free survival, overall survival, percentage of amputation, etc. Expert pathology peer review will be performed to detect differences between expert and non-expert centers as well as differences in treatment and patient prognosis. Tumor samples of 4 types of sarcoma would also be included in translational research to detect biomarkers and produce preclinical models.
Eligibility
Inclusion Criteria3
- Histological diagnosis of soft-tissue sarcoma, GIST or bone sarcoma (all subtypes) from January 2005 until Juny/September 2023.
- ≥ 18 years
- Available clinical and treatment information
Interventions
There is no intervention on study subjects. A tumor review will be performed by expert centers.
Locations(9)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04181970